Header Logo

Jessica Chubak, PhD, MBHL

TitleSenior Investigator
InstitutionKaiser Permanente Washington
DepartmentWashington Health Research Institute
Address1730 Minor Ave
Seattle WA 98101
ORCID ORCID IconLogin to create your ORCID iD Additional info
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    P01CA233432     (KUSHI, LAWRENCE H)Sep 15, 2020 - Jun 30, 2026
    NIH
    Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers
    Role: Co-Principal Investigator
    R01CA249127     (ADAMS, ALYCE SOPHIA)Jun 1, 2020 - May 31, 2025
    NIH
    Leveraging machine learning to improve risk prediction for chemotherapy inducedneuropathy
    Role: Co-Principal Investigator
    UM1CA222035     (CORLEY, DOUGLAS ALLEN)Apr 15, 2018 - Mar 31, 2025
    NIH
    Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)
    Role: Co-Principal Investigator
    UM1CA221940     (HUGHES, AMY E)Apr 10, 2018 - Mar 31, 2025
    NIH
    Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
    Role: Co-Principal Investigator
    UH3CA218909     (CHUBAK, JESSICA ;ETZIONI, RUTH D ;HUANG, BIN)Sep 25, 2017 - Jun 30, 2023
    NIH
    ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
    Role: Principal Investigator
    UG3CA218909     (ETZIONI, RUTH D)Sep 25, 2017 - Feb 29, 2020
    NIH
    ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement
    Role: Co-Principal Investigator
    R21HD091877     (CHUBAK, JESSICA)May 1, 2017 - Apr 30, 2021
    NIH
    Psychological benefits and potential pathogen transmission in hospitalized pediatric oncology patients receiving therapy dog visits: a randomized controlled trial
    Role: Principal Investigator
    R01CA172073     (CHUBAK, JESSICA)Sep 19, 2013 - Jul 31, 2018
    NIH
    Commonly Used Medications and Risk of Colorectal Cancer Recurrence
    Role: Principal Investigator
    R03CA169576     (CHUBAK, JESSICA)Apr 1, 2013 - Mar 31, 2016
    NIH
    Developing trials of animal-assisted activities for youth with cancer
    Role: Principal Investigator
    U54CA163261     (CHUBAK, JESSICA)Sep 1, 2011 - May 31, 2018
    NIH
    Studying Colorectal Cancer Effectiveness of Screening Strategies (SuCCESS)
    Role: Principal Investigator
    R03CA156357     (CHUBAK, JESSICA)Sep 1, 2011 - Aug 31, 2012
    NIH
    Risk of Non-Hodgkin's Lymphoma in Relation to Tricyclic Antidepressant Use
    Role: Principal Investigator
    R21CA143242     (CHUBAK, JESSICA)Jan 4, 2010 - Jun 30, 2012
    NIH
    Algorithms to Identify Second Breast Cancer Events from Electronic Data
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chubak J, Ichikawa LE, Merchant SA, Dalmat RR, Ziebell RA, Jensen CD, Lee JK, Corley DA, Ghai NR, Green BB, Skinner CS, Schottinger JE, Breslau ES, Levin TR. Incidence of serious complications following screening colonoscopy in adults aged 76 to 85 years old. Cancer Epidemiol Biomarkers Prev. 2024 Nov 25. PMID: 39585215.
      Citations:    Fields:    
    2. Figueroa Gray MS, Shapiro L, Dorsey CN, Randall S, Casperson M, Chawla N, Zebrack B, Fujii MM, Hahn EE, Keegan THM, Kirchhoff AC, Kushi LH, Nichols HB, Wernli KJ, Sauder CAM, Chubak J. A Patient-Centered Conceptual Model of AYA Cancer Survivorship Care Informed by a Qualitative Interview Study. Cancers (Basel). 2024 Sep 04; 16(17). PMID: 39272931; PMCID: PMC11394144.
      Citations:    
    3. Issaka RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, Clark CR, Del Vecchio NJ, Kamineni A, Neslund-Dudas C, Chubak J, Corley DA, Haas JS, Honda SA, Li CI, Winer RL, Pruitt SL. Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems. Cancer. 2024 Aug 09. PMID: 39119731.
      Citations:    Fields:    Translation:Humans
    4. Dang TH, Rieu-Werden ML, Kobrin SC, Tiro JA, Werner C, Lykken JM, Chubak J, Atlas SJ, Higashi RT, Lee SC, Haas JS, Skinner CS, Silver MI, Feldman S. Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results. J Gen Intern Med. 2024 Jul 25. PMID: 39060782.
      Citations:    Fields:    Translation:Humans
    5. Lu Y, Tong J, Chubak J, Lumley T, Hubbard RA, Xu H, Chen Y. Leveraging error-prone algorithm-derived phenotypes: Enhancing association studies for risk factors in EHR data. J Biomed Inform. 2024 Jul 14; 157:104690. PMID: 39004110.
      Citations:    Fields:    Translation:Humans
    6. Hahn EE, Munoz-Plaza CE, Jensen CD, Ghai NR, Pak K, Amundsen BI, Contreras R, Cannizzaro N, Chubak J, Green BB, Skinner CS, Halm EA, Schottinger JE, Levin TR. Patterns of Care Following a Positive Fecal Blood Test for Colorectal Cancer: A Mixed Methods Study. J Gen Intern Med. 2024 May 21. PMID: 38771535.
      Citations:    Fields:    Translation:Humans
    7. Wernli KJ, Haupt EC, Chawla N, Osuji T, Shen E, Smitherman AB, Casperson M, Kirchhoff AC, Zebrack BJ, Keegan THM, Kushi L, Baggett C, Kaddas HK, Ruddy KJ, Sauder CAM, Wun T, Figueroa Gray M, Chubak J, Nichols H, Hahn EE. Emergency Department Use in Adolescent and Young Adult Cancer Early Survivors from 2006 to 2020. J Adolesc Young Adult Oncol. 2024 Apr 29. PMID: 38682323.
      Citations:    Fields:    Translation:Humans
    8. Lee JK, Jensen CD, Udaltsova N, Zheng Y, Levin TR, Chubak J, Kamineni A, Halm EA, Skinner CS, Schottinger JE, Ghai NR, Burnett-Hartman A, Issaka R, Corley DA. Predicting Risk of Colorectal Cancer After Adenoma Removal in a Large Community-Based Setting. Am J Gastroenterol. 2024 Apr 11. PMID: 38354214.
      Citations:    Fields:    Translation:Humans
    9. Lee JK, Roy A, Jensen CD, Chan JT, Zhao WK, Levin TR, Chubak J, Halm EA, Skinner CS, Schottinger JE, Ghai NR, Burnett-Hartman AN, Kamineni A, Udaltsova N, Corley DA. Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas. JAMA Netw Open. 2024 Apr 01; 7(4):e244611. PMID: 38564216; PMCID: PMC10988351.
      Citations:    Fields:    Translation:Humans
    10. Abrah?o R, Brunson A, Chubak J, Wernli KJ, Nichols HB, Chao C, Ruddy KJ, Hahn EE, Li Q, Malogolowkin MH, Sauder CAM, Kushi LH, Wun T, Keegan THM. Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California. Thromb Res. 2024 Jan 15; 235:1-7. PMID: 38244373.
      Citations:    Fields:    Translation:Humans
    11. Rasouli B, Chubak J, Floyd JS, Psaty BM, Nguyen M, Walker RL, Wiggins KL, Logan RW, Danaei G. Combining high quality data with rigorous methods: emulation of a target trial using electronic health records and a nested case-control design. BMJ. 2023 12 28; 383:e072346. PMID: 38154827.
      Citations: 1     Fields:    Translation:Humans
    12. White LL, Burnett-Hartman AN, Ichikawa LE, Goldberg SR, Chubak J, Spencer Feigelson H, Kamineni A. SARS-CoV-2 Infection and Related Hospitalization Among Cancer Survivors. Cancer Epidemiol Biomarkers Prev. 2023 Dec 21. PMID: 38126877.
      Citations:    Fields:    Translation:HumansCells
    13. Aiello Bowles EJ, Kroenke CH, Chubak J, Bhimani J, O'Connell K, Brandzel S, Valice E, Doud R, Theis MK, Roh JM, Heon N, Persaud S, Griggs JJ, Bandera EV, Kushi LH, Kantor ED. Evaluation of algorithms using automated health plan data to identify breast cancer recurrences. Cancer Epidemiol Biomarkers Prev. 2023 Dec 13. PMID: 38088912.
      Citations: 1     Fields:    Translation:Humans
    14. Chubak J, Adler A, Bobb JF, Hawkes RJ, Ziebell RA, Pocobelli G, Ludman EJ, Zerr DM. A Randomized Controlled Trial of Animal-assisted Activities for Pediatric Oncology Patients: Psychosocial and Microbial Outcomes. J Pediatr Health Care. 2023 Nov 04. PMID: 37930283.
      Citations: 1     Fields:    Translation:HumansAnimalsPHPublic Health
    15. Alimena S, Lykken JM, Tiro JA, Chubak J, Kamineni A, Haas JS, Werner C, Kobrin SC, Feldman S. Timing of Colposcopy and Risk of Cervical Cancer. Obstet Gynecol. 2023 11 01; 142(5):1125-1134. PMID: 37607530.
      Citations:    Fields:    Translation:HumansCells
    16. Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Burnett-Hartman AN, Corley DA, Doria-Rose VP, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J. Risk of colorectal cancer and colorectal cancer mortality beginning one year after a negative fecal occult blood test, among screen-eligible 76-85-year-olds. Cancer Epidemiol Biomarkers Prev. 2023 Jul 14. PMID: 37450838.
      Citations:    Fields:    Translation:HumansPHPublic Health
    17. McCarthy AM, Tiro JA, Hu E, Ehsan S, Chubak J, Kamineni A, Feldman S, Atlas SJ, Silver MI, Kobrin S, Haas JS. Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systems. Prev Med Rep. 2023 Oct; 35:102279. PMID: 37361923; PMCID: PMC10285268.
      Citations: 1     
    18. Corley DA, Jensen CD, Chubak J, Schottinger JE, Halm EA, Udaltsova N, Prospr Precise Consortium. Evaluating Different Approaches for Calculating Adenoma Detection Rate: Is Screening Colonoscopy the Gold Standard? Gastroenterology. 2023 09; 165(3):784-787.e4. PMID: 37263304.
      Citations: 2     Fields:    Translation:Humans
    19. Selby K, Sedki M, Levine E, Kamineni A, Green BB, Vachani A, Haas JS, Ritzwoller DP, Croswell JM, Ohikere K, Doria-Rose VP, Rendle KA, Chubak J, Lafata JE, Inadomi J, Corley DA. Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review. J Natl Cancer Inst. 2023 Feb 08. PMID: 36752508.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    20. Del Vecchio NJ, Beaber EF, Garcia MP, Wheeler CM, Kamineni A, Chao C, Chubak J, Corley DA, Owens CL, Winer RL, Pruitt SL, Raine-Bennett T, Feldman S, Silverberg M. Provider- and Facility-Level Variation in Pre-Cancerous Cervical Biopsy Diagnoses. J Low Genit Tract Dis. 2023 Jan 17. PMID: 36728078.
      Citations:    Fields:    Translation:Humans
    21. Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Corley DA, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J. Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45. PMID: 36099431; PMCID: PMC9839620.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    22. Feldman S, Lykken JM, Haas JS, Werner CL, Kobrin SC, Tiro JA, Chubak J, Kamineni A. Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 11; 164:107307. PMID: 36270434; PMCID: PMC9808794.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    23. Chubak J, Pocobelli G, Ziebell RA, Hawkes RJ, Adler A, Bobb JF, Zerr DM. Effects of the COVID-19 Pandemic on Animal-Assisted Activities in Pediatric Hospitals. J Pediatr Health Care. 2022 Sep 30. PMID: 36266165; PMCID: PMC9547756.
      Citations:    Fields:    Translation:HumansAnimalsPHPublic Health
    24. Kamineni A, Doria-Rose VP, Chubak J, Inadomi JM, Corley DA, Haas JS, Kobrin SC, Winer RL, Elston Lafata J, Beaber EF, Yudkin JS, Zheng Y, Skinner CS, Schottinger JE, Ritzwoller DP, Croswell JM, Burnett-Hartman AN. Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590. PMID: 36162112; PMCID: PMC9903969.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    25. Chubak J, Dalmat RR, Weiss NS, Doria-Rose VP, Corley DA, Kamineni A. Informative Presence in Electronic Health Record Data: A Challenge in Implementing Study Exclusion Criteria. Epidemiology. 2023 Jan 01; 34(1):29-32. PMID: 36125348; PMCID: PMC9722536.
      Citations: 2     Fields:    Translation:Humans
    26. Chao CR, Chubak J, Beaber EF, Kamineni A, Mao C, Silverberg MJ, Tiro JA, Skinner C, Garcia M, Corley DA, Winer RL, Raine-Bennett T, Feldman S, Wheeler CM. Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2023 Feb; 12(3):3705-3717. PMID: 36106421; PMCID: PMC9939213.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    27. Beaber EF, Kamineni A, Burnett-Hartman AN, Hixon B, Kobrin SC, Li CI, Oliver M, Rendle KA, Skinner CS, Todd K, Zheng Y, Ziebell RA, Breslau ES, Chubak J, Corley DA, Greenlee RT, Haas JS, Halm EA, Honda S, Neslund-Dudas C, Ritzwoller DP, Schottinger JE, Tiro JA, Vachani A, Doria-Rose VP. Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1521-1531. PMID: 35916603; PMCID: PMC9350927.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    28. Chubak J, Burnett-Hartman AN, Barlow WE, Corley DA, Croswell JM, Neslund-Dudas C, Vachani A, Silver MI, Tiro JA, Kamineni A. Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1517-1520. PMID: 35916602; PMCID: PMC9484579.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    29. Nicholson BD, Thompson MJ, Hobbs FDR, Nguyen M, McLellan J, Green B, Chubak J, Oke JL. Measured weight loss as a precursor to cancer diagnosis: retrospective cohort analysis of 43 302 primary care patients. J Cachexia Sarcopenia Muscle. 2022 Oct; 13(5):2492-2503. PMID: 35903866; PMCID: PMC9530580.
      Citations: 9     Fields:    Translation:Humans
    30. Sarma EA, Thompson MJ, Bowles EJA, Burnett-Hartman AN, Hubbard RA, Yu O, Chubak J. Patient and tumour characteristics of screening-age adults diagnosed with screen-detected versus symptomatic colon cancer. Colorectal Dis. 2022 Jun 23. PMID: 35739634.
      Citations:    Fields:    Translation:HumansPHPublic Health
    31. Schottinger JE, Jensen CD, Ghai NR, Chubak J, Lee JK, Kamineni A, Halm EA, Sugg-Skinner C, Udaltsova N, Zhao WK, Ziebell RA, Contreras R, Kim EJ, Fireman BH, Quesenberry CP, Corley DA. Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer. JAMA. 2022 06 07; 327(21):2114-2122. PMID: 35670788; PMCID: PMC9175074.
      Citations: 24     Fields:    Translation:Humans
    32. Pocobelli G, Ichikawa L, Yu O, Green BB, Meyers K, Gray R, Shea M, Chubak J. Validation of international classification of diseases, tenth revision, clinical modification diagnosis codes for heart failure subtypes. Pharmacoepidemiol Drug Saf. 2022 Jun 07. PMID: 35670124.
      Citations: 1     Fields:    Translation:Humans
    33. Chubak J, Lund JL. Noncancer comparators in cancer survivorship studies. Cancer. 2022 08 01; 128(15):2994. PMID: 35503856.
      Citations:    Fields:    Translation:Humans
    34. Nichols HB, Wernli KJ, Chawla N, O'Meara ES, Gray MF, Green LE, Baggett CD, Casperson M, Chao C, Jones SMW, Kirchhoff AC, Kuo TM, Lee C, Malogolowkin M, Quesenberry CP, Ruddy KJ, Wun T, Zebrack B, Chubak J, Hahn EE, Keegan THM, Kushi LH. Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young Adults. Curr Epidemiol Rep. 2023 Sep; 10(3):115-124. PMID: 37700859; PMCID: PMC10495081.
      Citations:    
    35. Liu X, Chubak J, Hubbard RA, Chen Y. SAT: a Surrogate-Assisted Two-wave case boosting sampling method, with application to EHR-based association studies. J Am Med Inform Assoc. 2021 Dec 28. PMID: 34962283.
      Citations: 2     Fields:    
    36. Haas JS, Cheng D, Yu L, Atlas SJ, Clark C, Feldman S, Silver MI, Kamineni A, Chubak J, Pocobelli G, Tiro JA, Kobrin SC. Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics. Prev Med. 2022 Jan; 154:106871. PMID: 34762966; PMCID: PMC8724456.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    37. Zhu Y, Hubbard RA, Chubak J, Roy J, Mitra N. Core concepts in pharmacoepidemiology: Violations of the positivity assumption in the causal analysis of observational data: Consequences and statistical approaches. Pharmacoepidemiol Drug Saf. 2021 Aug 10. PMID: 34375473.
      Citations: 13     Fields:    Translation:Humans
    38. Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Meenan RT, Vernon SW. A Centralized Program with Stepped Support Increases Adherence to Colorectal Cancer Screening Over 9 Years: a Randomized Trial. J Gen Intern Med. 2021 May 28. PMID: 34047921; PMCID: PMC8162159.
      Citations: 3     Fields:    Translation:Humans
    39. Hubbard RA, Lett E, Ho GYF, Chubak J. Characterizing Bias Due to Differential Exposure Ascertainment in Electronic Health Record Data. Health Serv Outcomes Res Methodol. 2021 Sep; 21(3):309-323. PMID: 34366704; PMCID: PMC8336686.
      Citations: 4     
    40. Chubak J, Hawkes R, Dudzik C, Ziebell RA, Sherman KJ. Letter: The Choice of Control Conditions in Animal-Assisted Intervention Research. Integr Cancer Ther. 2021 Jan-Dec; 20:15347354211025626. PMID: 34166147; PMCID: PMC8236761.
      Citations:    Fields:    Translation:Animals
    41. Ghai NR, Jensen CD, Merchant SA, Schottinger JE, Lee JK, Chubak J, Kamineni A, Halm EA, Skinner CS, Haas JS, Green BB, Cannizzaro NT, Schneider JL, Corley DA. Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems. Cancer Prev Res (Phila). 2020 11; 13(11):947-958. PMID: 32669318; PMCID: PMC7641998.
      Citations: 7     Fields:    Translation:Humans
    42. Zheng Y, Corley DA, Doubeni C, Halm E, Shortreed SM, Barlow WE, Zauber A, Tosteson TD, Chubak J. ANALYSES OF PREVENTIVE CARE MEASURES WITH INCOMPLETE HISTORICAL DATA IN ELECTRONIC MEDICAL RECORDS: AN EXAMPLE FROM COLORECTAL CANCER SCREENING. Ann Appl Stat. 2020 Jun; 14(2):1030-1044. PMID: 34531936; PMCID: PMC8442666.
      Citations: 1     
    43. Chubak J, Anderson ML, Cook AJ, Murphy CC, Jackson ML, Green BB. Methodologic Considerations in Calculating and Analyzing Proportion of Time Covered as a Measure of Longitudinal Cancer Screening Adherence. Cancer Epidemiol Biomarkers Prev. 2020 08; 29(8):1549-1556. PMID: 32467346; PMCID: PMC7415680.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    44. Hua X, Newcomb PA, Chubak J, Malen RC, Ziebell R, Kamineni A, Zhu LC, Upton MP, Wurscher MA, Thomas SS, Newman H, Hardikar S, Burnett-Hartman AN. Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control. 2020 Jul; 31(7):631-640. PMID: 32358694; PMCID: PMC8259952.
      Citations: 3     Fields:    Translation:HumansCells
    45. Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, Onega T, Quinn VP, Schapira MM, Tosteson ANA, Corley DA, Skinner CS, Schnall MD, Armstrong K, Wheeler CM, Silverberg MJ, Balasubramanian BA, Doubeni CA, McLerran D, Tiro JA. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 03 01; 112(3):238-246. PMID: 31292633; PMCID: PMC7073922.
      Citations: 24     Fields:    Translation:Humans
    46. Tong J, Huang J, Chubak J, Wang X, Moore JH, Hubbard RA, Chen Y. An augmented estimation procedure for EHR-based association studies accounting for differential misclassification. J Am Med Inform Assoc. 2020 02 01; 27(2):244-253. PMID: 31617899; PMCID: PMC7025368.
      Citations: 11     Fields:    Translation:Humans
    47. Chen L, Chubak J, Yu O, Pocobelli G, Ziebell RA, Aiello Bowles EJ, Fujii MM, Sterrett AT, Boggs JM, Burnett-Hartman AN, Ritzwoller DP, Hubbard RA, Boudreau DM. Changes in use of opioid therapy after colon cancer diagnosis: a population-based study. Cancer Causes Control. 2019 Dec; 30(12):1341-1350. PMID: 31667710; PMCID: PMC6863090.
      Citations: 5     Fields:    Translation:Humans
    48. Lee JK, Jensen CD, Levin TR, Doubeni CA, Zauber AG, Chubak J, Kamineni AS, Schottinger JE, Ghai NR, Udaltsova N, Zhao WK, Fireman BH, Quesenberry CP, Orav EJ, Skinner CS, Halm EA, Corley DA. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5. PMID: 31589872; PMCID: PMC7083250.
      Citations: 37     Fields:    Translation:Humans
    49. Check DK, Hutcheson KA, Poisson LM, Pocobelli G, Sakoda LC, Zaveri J, Chang SS, Chubak J. Factors associated with employment discontinuation among older and working age survivors of oropharyngeal cancer. Head Neck. 2019 11; 41(11):3948-3959. PMID: 31490588.
      Citations: 7     Fields:    Translation:Humans
    50. Burnett-Hartman AN, Kamineni A, Corley DA, Singal AG, Halm EA, Rutter CM, Chubak J, Lee JK, Doubeni CA, Inadomi JM, Doria-Rose VP, Zheng Y. Colonoscopy Indication Algorithm Performance Across Diverse Health Care Systems in the PROSPR Consortium. EGEMS (Wash DC). 2019 Aug 02; 7(1):37. PMID: 31531383; PMCID: PMC6676916.
      Citations: 7     
    51. Pocobelli G, Ziebell R, Fujii M, Hutcheson KA, Chang S, McClure JB, Chubak J. Symptom Burden in Long-Term Survivors of Head and Neck Cancer: Patient-Reported Versus Clinical Data. EGEMS (Wash DC). 2019 Jul 10; 7(1):25. PMID: 31328132; PMCID: PMC6625536.
      Citations: 1     
    52. Burnett-Hartman AN, Chubak J, Hua X, Ziebell R, Kamineni A, Zhu LC, Upton MP, Malen RC, Hardikar S, Newcomb PA. The association between colorectal sessile serrated adenomas/polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control. 2019 Sep; 30(9):979-987. PMID: 31290073; PMCID: PMC6736607.
      Citations: 5     Fields:    Translation:Humans
    53. Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Kimbel KJ, Kullgren JT, Meenan RT, Vernon SW. Financial Incentives to Increase Colorectal Cancer Screening Uptake and Decrease Disparities: A Randomized Clinical Trial. JAMA Netw Open. 2019 07 03; 2(7):e196570. PMID: 31276178; PMCID: PMC6789432.
      Citations: 22     Fields:    Translation:Humans
    54. Burnett-Hartman AN, Powers JD, Chubak J, Corley DA, Ghai NR, McMullen CK, Pawloski PA, Sterrett AT, Feigelson HS. Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network. Cancer Causes Control. 2019 Jul; 30(7):747-755. PMID: 31102084.
      Citations: 31     Fields:    Translation:Humans
    55. Breen N, Skinner CS, Zheng Y, Inrig S, Corley DA, Beaber EF, Garcia M, Chubak J, Doubeni C, Quinn VP, Haas JS, Li CI, Wernli KJ, Klabunde CN. Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type. Am J Prev Med. 2019 May; 56(5):e143-e152. PMID: 31003603.
      Citations: 9     Fields:    Translation:Humans
    56. Clarke CL, Kushi LH, Chubak J, Pawloski PA, Bulkley JE, Epstein MM, Burnett-Hartman AN, Powell B, Pearce CL, Spencer Feigelson H. Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients. Cancer Epidemiol Biomarkers Prev. 2019 Apr 09. PMID: 30967418.
      Citations: 11     Fields:    Translation:Humans
    57. Boudreau DM, Chen L, Yu O, Bowles EJA, Chubak J. Risk of second breast cancer events with chronic opioid use in breast cancer survivors. Pharmacoepidemiol Drug Saf. 2019 Apr 03. PMID: 30945381.
      Citations: 7     Fields:    Translation:Humans
    58. Haas CB, Phipps AI, Hajat A, Chubak J, Wernli KJ. Time to fecal immunochemical test completion for colorectal cancer screening. Am J Manag Care. 2019 Apr; 25(4):174-180. PMID: 30986014.
      Citations: 5     Fields:    Translation:Humans
    59. Bowles EJA, Yu O, Ziebell R, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Boggs JM, Burnett-Hartman AN, Sterrett A, Fujii M, Chubak J. Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study. BMC Cancer. 2019 Mar 27; 19(1):270. PMID: 30917783.
      Citations: 7     Fields:    Translation:Humans
    60. Pocobelli G, Yu O, Ziebell RA, Aiello Bowles EJ, Fujii MM, Sterrett AT, Boggs JM, Chen L, Boudreau DM, Ritzwoller DP, Hubbard RA, Chubak J. Use of antidepressants after colon cancer diagnosis and risk of recurrence. Psychooncology. 2019 Apr; 28(4):750-758. PMID: 30703275.
      Citations: 3     Fields:    Translation:Humans
    61. Aiello Bowles EJ, Crane PK, Walker RL, Chubak J, LaCroix AZ, Anderson ML, Rosenberg D, Keene CD, Larson EB. Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain. J Alzheimers Dis. 2019; 68(3):1071-1083. PMID: 30909217.
      Citations: 26     Fields:    Translation:Humans
    62. Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Paul Doria-Rose V. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort. Int J Cancer. 2019 Mar 15; 144(6):1460-1473. PMID: 30353911.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    63. Mayer SE, Weiss NS, Chubak J, Doody DR, Carlson CS, Makar KW, Wurscher MA, Malone KE. CYP2D6-inhibiting medication use and inherited CYP2D6 variation in relation to adverse breast cancer outcomes after tamoxifen therapy. Cancer Causes Control. 2019 Jan; 30(1):103-112. PMID: 30542984.
      Citations: 2     Fields:    Translation:Humans
    64. Reed SC, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J, Nekhlyudov L. Cancer Survivors' Reported Discussions with Health Care Providers About Follow-Up Care and Receipt of Written Care Plans. J Cancer Educ. 2018 Dec; 33(6):1181-1188. PMID: 28480500.
      Citations: 6     Fields:    Translation:Humans
    65. Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF. Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems. Cancer Epidemiol Biomarkers Prev. 2019 Jan; 28(1):91-98. PMID: 30459208.
      Citations: 7     Fields:    Translation:Humans
    66. Chen Y, Wang J, Chubak J, Hubbard RA. Inflation of type I error rates due to differential misclassification in EHR-derived outcomes: Empirical illustration using breast cancer recurrence. Pharmacoepidemiol Drug Saf. 2019 Feb; 28(2):264-268. PMID: 30375122.
      Citations: 12     Fields:    Translation:Humans
    67. Chubak J, Yu O, Ziebell RA, Bowles EJA, Sterrett AT, Fujii MM, Boggs JM, Burnett-Hartman AN, Boudreau DM, Chen L, Floyd JS, Ritzwoller DP, Hubbard RA. Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control. 2018 Nov; 29(11):1093-1103. PMID: 30244297.
      Citations: 9     Fields:    Translation:Humans
    68. Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, Chubak J, Halm E, Ghai NR, Contreras R, Skinner C, Kamineni A, Levin TR, Corley DA. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study. Ann Intern Med. 2018 Oct 02; 169(7):439-447. PMID: 30242328.
      Citations: 16     Fields:    Translation:Humans
    69. Jones SMW, Walker R, Fujii M, Nekhlyudov L, Rabin BA, Chubak J. Financial difficulty, worry about affording care, and benefit finding in long-term survivors of cancer. Psychooncology. 2018 04; 27(4):1320-1326. PMID: 29462511.
      Citations: 13     Fields:    Translation:Humans
    70. Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, Quinn VP, Jensen CD, Chubak J, Tiro J, Doubeni CA, Ghai NR, Skinner CS, Wernli K, Halm EA. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018 May; 113(5):746-754. PMID: 29487413.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    71. Chubak J, Onega T, Zhu W, Buist DSM, Hubbard RA. An Electronic Health Record-based Algorithm to Ascertain the Date of Second Breast Cancer Events. Med Care. 2017 12; 55(12):e81-e87. PMID: 29135770.
      Citations: 15     Fields:    Translation:Humans
    72. Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI. Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis. Cancer Res. 2017 11 01; 77(21):6033-6041. PMID: 28935814.
      Citations: 20     Fields:    Translation:Humans
    73. Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population. Cancer Epidemiol Biomarkers Prev. 2017 11; 26(11):1603-1610. PMID: 28807926.
      Citations: 17     Fields:    Translation:Humans
    74. Singal AG, Tiro J, Li X, Adams-Huet B, Chubak J. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System. J Clin Gastroenterol. 2017 Aug; 51(7):650-655. PMID: 27870642.
      Citations: 26     Fields:    Translation:HumansPHPublic Health
    75. Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Meenan RT, Vernon SW. A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer. 2017 Nov 15; 123(22):4472-4480. PMID: 28753230.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    76. Chubak J, Hawkes R, Dudzik C, Foose-Foster JM, Eaton L, Johnson RH, Macpherson CF. Pilot Study of Therapy Dog Visits for Inpatient Youth With Cancer. J Pediatr Oncol Nurs. 2017 Sep/Oct; 34(5):331-341. PMID: 28614971.
      Citations: 16     Fields:    Translation:HumansAnimals
    77. Hardikar S, Burnett-Hartman AN, Chubak J, Upton MP, Zhu LC, Potter JD, Newcomb PA. Reproductive factors and risk of colorectal polyps in a colonoscopy-based study in western Washington State. Cancer Causes Control. 2017 03; 28(3):241-246. PMID: 28205046.
      Citations: 1     Fields:    Translation:Humans
    78. Jones SM, Ziebell R, Walker R, Nekhlyudov L, Rabin BA, Nutt S, Fujii M, Chubak J. Association of worry about cancer to benefit finding and functioning in long-term cancer survivors. Support Care Cancer. 2017 05; 25(5):1417-1422. PMID: 27981365.
      Citations: 8     Fields:    Translation:Humans
    79. Shortreed SM, Johnson E, Rutter CM, Kamineni A, Wernli KJ, Chubak J. Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk. Obs Stud. 2016 Aug; 2:51-64. PMID: 28530002.
      Citations: 2     
    80. Chubak J, Ziebell R, Greenlee RT, Honda S, Hornbrook MC, Epstein M, Nekhlyudov L, Pawloski PA, Ritzwoller DP, Ghai NR, Feigelson HS, Clancy HA, Doria-Rose VP, Kushi LH. The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016 11; 27(11):1315-1323. PMID: 27639398.
      Citations: 27     Fields:    Translation:Humans
    81. Klabunde CN, Zheng Y, Quinn VP, Beaber EF, Rutter CM, Halm EA, Chubak J, Doubeni CA, Haas JS, Kamineni A, Schapira MM, Vacek PM, Garcia MP, Corley DA. Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med. 2016 09; 51(3):e67-75. PMID: 27344108.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    82. Nekhlyudov L, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J. Cancer survivors' experiences with insurance, finances, and employment: results from a multisite study. J Cancer Surviv. 2016 12; 10(6):1104-1111. PMID: 27277896.
      Citations: 39     Fields:    Translation:Humans
    83. Halm EA, Beaber EF, McLerran D, Chubak J, Corley DA, Rutter CM, Doubeni CA, Haas JS, Balasubramanian BA. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med. 2016 10; 31(10):1190-7. PMID: 27279097.
      Citations: 25     Fields:    Translation:Humans
    84. Hubbard RA, Johnson E, Chubak J, Wernli KJ, Kamineni A, Bogart A, Rutter CM. Accounting for misclassification in electronic health records-derived exposures using generalized linear finite mixture models. Health Serv Outcomes Res Methodol. 2017 Jun; 17(2):101-112. PMID: 28943779.
      Citations: 7     
    85. Chubak J, Whitlock EP, Williams SB, Kamineni A, Burda BU, Buist DS, Anderson ML. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force. Ann Intern Med. 2016 Jun 21; 164(12):814-25. PMID: 27064482.
      Citations: 69     Fields:    Translation:HumansPHPublic Health
    86. Burnett-Hartman AN, Mehta SJ, Zheng Y, Ghai NR, McLerran DF, Chubak J, Quinn VP, Skinner CS, Corley DA, Inadomi JM, Doubeni CA. Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Am J Prev Med. 2016 10; 51(4):e107-15. PMID: 27050413.
      Citations: 47     Fields:    Translation:HumansPHPublic Health
    87. Chubak J, Hubbard R. Defining and measuring adherence to cancer screening. J Med Screen. 2016 12; 23(4):179-185. PMID: 26946420.
      Citations: 16     Fields:    Translation:Humans
    88. Green BB, Anderson ML, Chubak J, Baldwin LM, Tuzzio L, Catz S, Cole A, Vernon SW. Colorectal Cancer Screening Rates Increased after Exposure to the Patient-Centered Medical Home (PCMH). J Am Board Fam Med. 2016 Mar-Apr; 29(2):191-200. PMID: 26957375.
      Citations: 11     Fields:    Translation:Humans
    89. Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50. PMID: 26843520.
      Citations: 71     Fields:    Translation:HumansPHPublic Health
    90. Hubbard RA, Ripping TM, Chubak J, Broeders MJ, Miglioretti DL. Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes. Cancer Epidemiol Biomarkers Prev. 2016 Mar; 25(3):513-20. PMID: 26721668.
      Citations: 6     Fields:    Translation:Humans
    91. Chubak J, Hawkes R. Animal-Assisted Activities: Results From a Survey of Top-Ranked Pediatric Oncology Hospitals. J Pediatr Oncol Nurs. 2016 07; 33(4):289-96. PMID: 26589356.
      Citations: 8     Fields:    Translation:HumansAnimals
    92. Kroenke CH, Chubak J, Johnson L, Castillo A, Weltzien E, Caan BJ. Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data. J Natl Cancer Inst. 2016 Mar; 108(3). PMID: 26582243.
      Citations: 12     Fields:    Translation:Humans
    93. Chubak J, Bowles EJ, Yu O, Buist DS, Fujii M, Boudreau DM. Breast cancer recurrence in relation to antidepressant use. Cancer Causes Control. 2016 Jan; 27(1):125-36. PMID: 26518198.
      Citations: 16     Fields:    Translation:Humans
    94. Green BB, Anderson ML, Chubak J, Fuller S, Meenan RT, Vernon SW. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer. 2016 Jan 15; 122(2):312-21. PMID: 26488332.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    95. Jones SM, Ziebell R, Walker R, Nekhlyudov L, Rabin BA, Nutt S, Fujii M, Chubak J. Psychometric investigation of benefit finding among long-term cancer survivors using the Medical Expenditure Panel Survey. Eur J Oncol Nurs. 2016 Feb; 20:31-5. PMID: 26220893.
      Citations: 3     Fields:    Translation:Humans
    96. Meenan RT, Anderson ML, Chubak J, Vernon SW, Fuller S, Wang CY, Green BB. An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015 Jun; 48(6):714-21. PMID: 25998922.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    97. Adams KF, Johnson EA, Chubak J, Kamineni A, Doubeni CA, Buist DS, Williams AE, Weinmann S, Doria-Rose VP, Rutter CM. Development of an Algorithm to Classify Colonoscopy Indication from Coded Health Care Data. EGEMS (Wash DC). 2015; 3(1):1171. PMID: 26290883.
      Citations: 11     
    98. Ludman EJ, McCorkle R, Bowles EA, Rutter CM, Chubak J, Tuzzio L, Jones S, Reid RJ, Penfold R, Wagner EH. Do depressed newly diagnosed cancer patients differentially benefit from nurse navigation? Gen Hosp Psychiatry. 2015 May-Jun; 37(3):236-9. PMID: 25835508.
      Citations: 3     Fields:    Translation:Humans
    99. Chubak J, Hubbard RA, Johnson E, Kamineni A, Rutter CM. Assessing the effectiveness of a cancer screening test in the presence of another screening modality. J Med Screen. 2015 Jun; 22(2):69-75. PMID: 25492942.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    100. Green BB, Anderson ML, Wang CY, Vernon SW, Chubak J, Meenan RT, Fuller S. Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med. 2014 Nov-Dec; 27(6):789-95. PMID: 25381076.
      Citations: 31     Fields:    Translation:HumansPHPublic Health
    101. Murphy CC, Vernon SW, Haddock NM, Anderson ML, Chubak J, Green BB. Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014 Sep; 66:123-30. PMID: 24937648.
      Citations: 20     Fields:    Translation:Humans
    102. Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, Corley DA, Skinner CS, Chubak J, Doubeni CA, Halm EA, Gupta S, Wernli KJ, Klabunde C. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58. PMID: 24917182.
      Citations: 49     Fields:    Translation:Humans
    103. Wang CY, de Dieu Tapsoba J, Anderson ML, Vernon SW, Chubak J, Fuller S, Green BB. Time to screening in the systems of support to increase colorectal cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1683-8. PMID: 24891548.
      Citations: 2     Fields:    Translation:Humans
    104. Wernli KJ, Hubbard RA, Johnson E, Chubak J, Kamineni A, Green BB, Rutter CM. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1230-7. PMID: 24793956.
      Citations: 13     Fields:    Translation:Humans
    105. Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJ, Fujii M, Buist DS. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer. Breast Cancer Res Treat. 2014 Apr; 144(2):405-16. PMID: 24557337.
      Citations: 62     Fields:    Translation:Humans
    106. Chubak J, Aiello Bowles EJ, Tuzzio L, Ludman E, Rutter CM, Reid RJ, Wagner EH. Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv. 2014 Jun; 8(2):229-38. PMID: 24352871.
      Citations: 11     Fields:    Translation:Humans
    107. Wagner EH, Ludman EJ, Aiello Bowles EJ, Penfold R, Reid RJ, Rutter CM, Chubak J, McCorkle R. Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol. 2014 Jan 01; 32(1):12-8. PMID: 24276777.
      Citations: 68     Fields:    Translation:Humans
    108. Laing SS, Bogart A, Chubak J, Fuller S, Green BB. Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):154-9. PMID: 24220914.
      Citations: 18     Fields:    Translation:Humans
    109. Hamilton JG, Birmingham WC, Tehranifar P, Irwin ML, Klein WM, Nebeling L, Chubak J. Transitioning to independence and maintaining research careers in a new funding climate: american society of preventive oncology junior members interest group report. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):2138-42. PMID: 24190867.
      Citations: 2     Fields:    Translation:Humans
    110. Chubak J, Bogart A, Fuller S, Laing SS, Green BB. Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med. 2013 Nov; 57(5):671-8. PMID: 24029556.
      Citations: 21     Fields:    Translation:Humans
    111. Chubak J, Boudreau DM, Wirtz HS, McKnight B, Weiss NS. Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. J Natl Cancer Inst. 2013 Oct 02; 105(19):1456-62. PMID: 23940288.
      Citations: 59     Fields:    Translation:Humans
    112. Wirtz HS, Buist DS, Gralow JR, Barlow WE, Gray S, Chubak J, Yu O, Bowles EJ, Fujii M, Boudreau DM. Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1588-99. PMID: 23833124.
      Citations: 26     Fields:    Translation:Humans
    113. Chubak J, Yu O, Buist DS, Wirtz HS, Boudreau DM. Time scale in follow-up studies: considering disease prognosis. Epidemiology. 2013 Jul; 24(4):628-9. PMID: 23732747.
      Citations: 2     Fields:    Translation:Humans
    114. Lowry SJ, Chubak J, Press OW, McKnight B, Weiss NS. Risk of non-Hodgkin lymphoma in relation to tricyclic antidepressant use. Ann Epidemiol. 2013 Jun; 23(6):349-54. PMID: 23683711.
      Citations: 2     Fields:    Translation:Humans
    115. Chubak J, Rutter CM, Kamineni A, Johnson EA, Stout NK, Weiss NS, Doria-Rose VP, Doubeni CA, Buist DS. Measurement in comparative effectiveness research. Am J Prev Med. 2013 May; 44(5):513-9. PMID: 23597816.
      Citations: 1     Fields:    Translation:Humans
    116. Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, Rutter CM, Doria-Rose VP, Corley DA, Greenlee RT, Chubak J, Williams A, Kroll-Desrosiers AR, Johnson E, Webster J, Richert-Boe K, Levin TR, Fletcher RH, Weiss NS. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20. PMID: 23460054.
      Citations: 77     Fields:    Translation:HumansPHPublic Health
    117. Green BB, Wang CY, Anderson ML, Chubak J, Meenan RT, Vernon SW, Fuller S. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):301-11. PMID: 23460053.
      Citations: 119     Fields:    Translation:HumansPHPublic Health
    118. Nekhlyudov L, Greene SM, Chubak J, Rabin B, Tuzzio L, Rolnick S, Field TS. Cancer research network: using integrated healthcare delivery systems as platforms for cancer survivorship research. J Cancer Surviv. 2013 Mar; 7(1):55-62. PMID: 23239136.
      Citations: 10     Fields:    Translation:Humans
    119. Chubak J. What can epidemiology contribute to comparative effectiveness research? J Epidemiol Community Health. 2013 Mar; 67(3):206-7. PMID: 23180807.
      Citations:    Fields:    Translation:Humans
    120. Aiello Bowles EJ, Boudreau DM, Chubak J, Yu O, Fujii M, Chestnut J, Buist DS. Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. J Oncol Pract. 2012 Nov; 8(6):e149-57. PMID: 23598850.
      Citations: 55     Fields:    Translation:Humans
    121. Chubak J, Anderson ML, Saunders KW, Hubbard RA, Tuzzio L, Liss DT, Morales LS, Reid RJ. Predictors of 1-year change in patient activation in older adults with diabetes mellitus and heart disease. J Am Geriatr Soc. 2012 Jul; 60(7):1316-21. PMID: 22788389.
      Citations: 19     Fields:    Translation:Humans
    122. Pocobelli G, Chubak J, Hanson N, Drescher C, Resta R, Urban N, Buist DS. Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling. Gynecol Oncol. 2012 Aug; 126(2):229-35. PMID: 22564716.
      Citations: 5     Fields:    Translation:Humans
    123. Chubak J, Yu O, Pocobelli G, Lamerato L, Webster J, Prout MN, Ulcickas Yood M, Barlow WE, Buist DS. Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst. 2012 Jun 20; 104(12):931-40. PMID: 22547340.
      Citations: 67     Fields:    Translation:Humans
    124. Green BB, Bogart A, Chubak J, Vernon SW, Morales LS, Meenan RT, Laing SS, Fuller S, Ko C, Wang CY. Nonparticipation in a population-based trial to increase colorectal cancer screening. Am J Prev Med. 2012 Apr; 42(4):390-7. PMID: 22424252.
      Citations: 17     Fields:    Translation:HumansPHPublic Health
    125. Bowles EJ, Buist DS, Chubak J, Yu O, Johnson J, Chestnut J, Boudreau DM. Endocrine therapy initiation from 2001 to 2008 varies by age at breast cancer diagnosis and tumor size. J Oncol Pract. 2012 Mar; 8(2):113-20. PMID: 23077439.
      Citations: 13     Fields:    
    126. Chubak J, Tuzzio L, Hsu C, Alfano CM, Rabin BA, Hornbrook MC, Spegman A, Von Worley A, Williams A, Nekhlyudov L. Providing care for cancer survivors in integrated health care delivery systems: practices, challenges, and research opportunities. J Oncol Pract. 2012 May; 8(3):184-9. PMID: 22942814.
      Citations: 39     Fields:    
    127. Chubak J, Pocobelli G, Weiss NS. Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol. 2012 Mar; 65(3):343-349.e2. PMID: 22197520.
      Citations: 109     Fields:    Translation:Humans
    128. Liss DT, Chubak J, Anderson ML, Saunders KW, Tuzzio L, Reid RJ. Patient-reported care coordination: associations with primary care continuity and specialty care use. Ann Fam Med. 2011 Jul-Aug; 9(4):323-9. PMID: 21747103.
      Citations: 23     Fields:    Translation:Humans
    129. Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer. 2011 Jan 01; 128(1):227-32. PMID: 20232382.
      Citations: 24     Fields:    Translation:HumansAnimals
    130. Chubak J, Boudreau DM, Fishman PA, Elmore JG. Cost of breast-related care in the year following false positive screening mammograms. Med Care. 2010 Sep; 48(9):815-20. PMID: 20706161.
      Citations: 27     Fields:    Translation:HumansPHPublic Health
    131. Green BB, Wang CY, Horner K, Catz S, Meenan RT, Vernon SW, Carrell D, Chubak J, Ko C, Laing S, Bogart A. Systems of support to increase colorectal cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010 Nov; 31(6):589-603. PMID: 20674774.
      Citations: 29     Fields:    Translation:HumansPHPublic Health
    132. Buist DS, Chubak J, Prout M, Yood MU, Bosco JL, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, Wei F, Silliman RA. Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol. 2009 Sep 20; 27(27):4508-14. PMID: 19687341.
      Citations: 16     Fields:    Translation:Humans
    133. Hudson SV, Chubak J, Coups EJ, Blake-Gumbs L, Jacobsen PB, Neugut AI, Buist DS. Identifying key questions to advance research and practice in cancer survivorship follow-up care: a report from the ASPO Survivorship Interest Group. Cancer Epidemiol Biomarkers Prev. 2009 Jul; 18(7):2152-4. PMID: 19589917.
      Citations: 13     Fields:    Translation:Humans
    134. Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf. 2009 Jul; 18(7):540-4. PMID: 19367565.
      Citations: 15     Fields:    Translation:Humans
    135. Chubak J, Bowles EJ, Terry MB, Trentham-Dietz A, Buist DS. Antidepressant medications and change in mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2009 Feb; 18(2):676-9. PMID: 19190163.
      Citations:    Fields:    Translation:Humans
    136. Chubak J, Buist DS, Boudreau DM, Rossing MA, Lumley T, Weiss NS. Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat. 2008 Nov; 112(1):123-32. PMID: 18058227.
      Citations: 22     Fields:    Translation:Humans
    137. Chubak J, Doherty JA, Cushing-Haugen KL, Voigt LF, Saltzman BS, Hill DA, Beresford SA, Weiss NS. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy. Cancer Causes Control. 2007 Nov; 18(9):1001-7. PMID: 17653829.
      Citations: 3     Fields:    Translation:Humans
    138. Tworoger SS, Sorensen B, Chubak J, Irwin M, Stanczyk FZ, Ulrich CM, Potter J, McTiernan A. Effect of a 12-month randomized clinical trial of exercise on serum prolactin concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2007 May; 16(5):895-9. PMID: 17507612.
      Citations: 9     Fields:    Translation:Humans
    139. Rhew I, Yasui Y, Sorensen B, Ulrich CM, Neuhouser ML, Tworoger SS, Chubak J, Bowen DJ, McTiernan A. Effects of an exercise intervention on other health behaviors in overweight/obese post-menopausal women. Contemp Clin Trials. 2007 Jul; 28(4):472-81. PMID: 17287149.
      Citations: 9     Fields:    Translation:Humans
    140. Chubak J, Ulrich CM, Tworoger SS, Sorensen B, Yasui Y, Irwin ML, Stanczyk FZ, Potter JD, McTiernan A. Effect of exercise on bone mineral density and lean mass in postmenopausal women. Med Sci Sports Exerc. 2006 Jul; 38(7):1236-44. PMID: 16826020.
      Citations: 9     Fields:    Translation:Humans
    141. Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A. Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev. 2004 Aug; 13(8):1296-301. PMID: 15298949.
      Citations: 32     Fields:    Translation:Humans
    142. McTiernan A, Tworoger SS, Rajan KB, Yasui Y, Sorenson B, Ulrich CM, Chubak J, Stanczyk FZ, Bowen D, Irwin ML, Rudolph RE, Potter JD, Schwartz RS. Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2004 Jul; 13(7):1099-105. PMID: 15247119.
      Citations: 51     Fields:    Translation:HumansCTClinical Trials
    143. Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, Stanczyk FZ, McTiernan A. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004 Jan; 13(1):94-101. PMID: 14744739.
      Citations: 41     Fields:    Translation:Humans
    Concepts (293)
    Explore
    _
    Co-Authors (30)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    -->

    © 2024 Kaiser Permanente